PREVIOUS QUESTION:

 

NEXT QUESTION:

 

What are the types of chronic myeloproliferative disorders (MPDs)?

ANSWER

The kind of chronic myeloproliferative disorder (MPD) you have depends on which blood cells your body makes in excess. There are six types:

  • Chronic myelogenous leukemia: Too many immature white blood cells
  • Polycythemia vera: Too many red blood cells
  • Myelofibrosis: Too many immature white and red blood cells
  • Thrombocythemia: Too many platelets
  • Chronic neutrophilic leukemia: Too many neutrophils, a type of white blood cell
  • Eosinophilia: Too many eosinophils, a type of white blood cell

SOURCES:

The University of Texas MD Anderson Cancer Center: “Myeloproliferative Disorder,” “Myeloproliferative Disorder Facts,” Myeloproliferative Disorder Symptoms,” “Myeloproliferative Disorder Diagnosis.”

National Center for Advancing Translational Sciences/Genetic and Rare Diseases Information Center: “Chronic myeloproliferative disorders.”

University of California San Francisco Medical Center: “Myeloproliferative Disorders Signs and Symptoms,” “Myeloproliferative Disorders Treatment.”

Seattle Cancer Care Alliance: “Treatment Options.”

Dana-Farber Cancer Institute: “Myeloproliferative Disorder.”

Merck Manual, Consumer Version: “Overview of Myeloproliferative Disorders.”

National Cancer Institute: “Chronic Myeloproliferative Neoplasms Treatment (PDQ®)–Patient Version.”

Memorial Sloan Kettering Cancer Center: “Diagnosis and Treatment of Myeloproliferative Diseases,” Chronic Myeloproliferative Neoplasms Treatment (PDQ®) Patient Version.”

MPN Voice: “What Causes MPNs?”

Univeristy of California San Francisco: " Myeloproliferative Disorders Treatment."

Reviewed by Jennifer Robinson on May 13, 2019

SOURCES:

The University of Texas MD Anderson Cancer Center: “Myeloproliferative Disorder,” “Myeloproliferative Disorder Facts,” Myeloproliferative Disorder Symptoms,” “Myeloproliferative Disorder Diagnosis.”

National Center for Advancing Translational Sciences/Genetic and Rare Diseases Information Center: “Chronic myeloproliferative disorders.”

University of California San Francisco Medical Center: “Myeloproliferative Disorders Signs and Symptoms,” “Myeloproliferative Disorders Treatment.”

Seattle Cancer Care Alliance: “Treatment Options.”

Dana-Farber Cancer Institute: “Myeloproliferative Disorder.”

Merck Manual, Consumer Version: “Overview of Myeloproliferative Disorders.”

National Cancer Institute: “Chronic Myeloproliferative Neoplasms Treatment (PDQ®)–Patient Version.”

Memorial Sloan Kettering Cancer Center: “Diagnosis and Treatment of Myeloproliferative Diseases,” Chronic Myeloproliferative Neoplasms Treatment (PDQ®) Patient Version.”

MPN Voice: “What Causes MPNs?”

Univeristy of California San Francisco: " Myeloproliferative Disorders Treatment."

Reviewed by Jennifer Robinson on May 13, 2019

NEXT QUESTION:

What causes chronic myeloproliferative disorders (MPDs)?

WAS THIS ANSWER HELPFUL

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.